Guest guest Posted June 20, 2000 Report Share Posted June 20, 2000 Acuman1 wrote: > In a message dated 6/20/00 12:12:40 AM, wpettis writes: > > << 06/17/00 > > REQUEST FOR CLINICAL INVESTIGATORS > > William B. Pettis M.S., CCHM., Lac > Sponsored By: IAEPOM > International Association for the Ethical Practice of Oriental Medicine > > PIs: Choi, Seung Hoon, O.M.D., PhD, Kyung Hee University, Seoul Korea > Rhee, Jun Woo M.S., O.M.D., Kyung Hee University, Seoul Korea > William B. Pettis, M.S., CCHM., LAc., Memphis, Tennessee > Lee Chen ?Yr O.M.D., Taipei, Taiwan > > International Collaboration: Beijing College of Traditional > (Pending), Canmaul Hospital (Seoul) Pending. > > Please Forward > > Oriental Medicine, Quality of Life, and Breast Cancer Study > > Clinical investigators of Oriental Medicine (OM) are needed to conduct > study. This study will assess the “quality-of-life” of women, with stage ?II > breast cancer, who are being treated with Oriental Herbal Medicine (OHM), > while receiving chemotherapy. > > Selected investigators will possess the following: > > 1) An excellent understanding of Oriental Medicine as well as the ability to > use eclectic prescribing techniques. > 2) The ability to communicate with a diverse team of researchers, medical > oncologists and OM providers. > 3) The ability to understand and interpret serum blood counts, translating > appropriately and making the correct herbal modifications. > 4) National certification in Chinese Herbology and Acupuncture. To be > considered investigators must have taken and passed both examinations. Those > with honorable awarded certifications will not be eligible due to the > controls/design of this study. > 5) A Master’s Degree or higher. > 6) A clinical setting suitable for this study. > 7) The ability to attend training sessions related to this study. Travel > expenses will be reimbursed. > 8) The ability to use western biomedical language when working with our > research team. > > Other Information: > All subjects will receive chemotherapy. > Herbal medications are provided at no cost to the participant. > Chemotherapy is dependent on the study’s medical oncologists and the > subject’s current tumor staging. > Investigators are not paid but may be reimbursed for clinical time/use. > > Interested Clinicians: > > Enclose a current CV with a letter of request for application. All requests > will be held in confidence and answered in writing by one or all Principle > Investigators. > > The IAEPOM reserves the right to reject any applicant, request of > application, and/or terminate this study without notice. > > Send IAEPOM Study BRCA-OM-CL-1 > C/0 William Pettis > 6005 Park Ave Suite 511 > Memphis, TN 38119 > > Or e-mail wpettis > > The IAEPOM is a non-profit corporation. The IAEPOM honors cultural diversity > and does not discriminate based on age, religion, race, national origin, > gender, sexual orientation, handicap, political affiliation or economic > status. > >> Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.